Savient Gets Nod For Ch. 11 Disclosure Statement

A Delaware bankruptcy judge on Monday approved Savient Pharmaceuticals Inc.'s Chapter 11 disclosure statement, allowing the drug developer to solicit votes for a liquidation plan that would see creditors divvy up proceeds from its $120 million sale ...read more

  • Tags: